Following its recognition in 1981, the HIV/AIDS epidemic has evolved to become the
greatest challenge in global health, with some 34 million persons living with HIV worldwide …

Infection with human immunodeficiency virus type 2 (HIV-2) occurs mainly in West Africa, but
an increasing number of cases have been recognized in Europe, India, and the United …

This book grew out of a scientific review, originally published in Microbiological Reviews. It
has been updated and expanded-now citing more than 2100 references (100 pages of the …

The human immunodeficiency virus (HIV) epidemic continues to take a heavy toll on women
and children worldwide. In 2008, 33.4 million individuals were living with HIV, of whom 15.7 …

The AIDS pandemic continues to spread unchecked in many parts of the world, with greater
than 34 million individuals currently infected with human immunodeficiency virus (HIV) …

Summary Background In Africa, the risk of mother-to-child transmission of HIV-1 infection is
high. Short-course perinatal oral zidovudine might decrease the rate of transmission. We …

Background Zidovudine reduces the rate of vertical transmission of HIV in non-breastfed
populations. We assessed the acceptability, tolerance, and 6-month efficacy of a short …

From a prospective cohort study of 1948 initially human immunodeficiency virus (HIV)
uninfected female commercial sex workers followed between 1985 and 1999 in Dakar …

Human immunodeficiency virus type 2 (HIV-2) is less pathogenic than HIV type 1 (HIV-1),
but the mechanisms underlying this difference have not been defined. We developed an …

Objective. To compare morbidity and mortality of human immunodeficiency virus type 1 (HIV-
1)-infected and HIV-1-uninfected children and to identify predictors of acquired …